Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
Jefferson M. Jones(National Center for Immunization and Respiratory Diseases), Michael P. Busch(Vitalant)
Cited by 218
Related Papers
Prevention of transfusion-transmitted infections
|Blood|2019|297
Use of laboratory tests and clinical symptoms for identification of primary HIV infection
|AIDS|2002|296
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
|Science Advances|2021|150
Transfusion-transmitted arboviruses
|Vox Sanguinis|2009|129